Development in circulating tumor cells (CTCs) technologies represents a valuable tool for the better understanding of tumor biology. The clinical relevance of CTCs as a prognostic factor is well ...

circulating tumor cell (CTC) count at the start of treatment may be able to indicate which patients are likely to live longer after treatment, as well as those who may be good candidates for novel ...

Objectives: We focus on utilizing the Labyrinth system for the detection of circulating tumor cells (CTCs) in patients with lung nodules ... Compared to typical white blood cells from the slide with ...

Circulating tumor cells (CTCs), originating from primary neoplastic tissues, infiltrate blood vessels, migrate through the bloodstream, and establish secondary tumor foci. The detection of CTCs ...

Liquid biopsy (LB) is essential in precision medicine, enabling real-time tumor monitoring through repeated sampling. However, its diagnostic sensitivity and accuracy are limited by the low detection ...

1ANGLE plc, Guildford, United Kingdom.

Circulating tumor cells (CTCs), which are tumor cells released into the bloodstream from primary neoplastic sites, offer a promising avenue for non-invasive cancer diagnostics. This review ...

This is what helps the cancer cells retain their “immortality.” However, when the researchers tethered BCL6 with a protein called CDK9, they found that it acted as a catalyst for gene activation.

Turns out cancer cells might use our very own protein factories to hide. Each of our cells contain a million of these minuscule factories, called ribosomes. Liam: "They make all the protein we need.

Tumor-initiating cells (TICs), a distinct and critical subset of cancer cells, exhibit enhanced stemness and tumorigenic capabilities. These cells are characterized by their high plasticity, emerging ...